• Notice of clarification to drug manufacturers and sponsors - Risk Management Plans …
• Submitting risk management plans draft guidance document: Canadian-specific addendum template
• Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications
• Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program …
• Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in …